Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Amino Acids|April 1, 2009
Identification of flooding stress responsible cascades in root and hypocotyl of soybean using proteome analysisSetsuko Komatsu, Tetsuya Sugimoto, Tomoki Hoshino, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 22, 2022
Robust and Transparent Antifogging Polysilsesquioxane Film Containing a Hydroxy GroupTakashi Hamada, Tetsuya Sugimoto, Tetsuya Maeda, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structureNobuhiko Kawanishi, Tetsuya Sugimoto, Jun Shibata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2006
Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infectionQingwei Zhang, Mitsuo Takahashi, Yasushi Noguchi, et al.
The American Journal of Clinical Nutrition|February 14, 2006
Network analysis of plasma and tissue amino acids and the generation of an amino index for potential diagnostic useYasushi Noguchi, Qing-Wei Zhang, Tetsuya Sugimoto, et al.
Molecular Cancer Therapeutics|October 31, 2023
TAS0612, a Novel RSK, AKT, and S6K Inhibitor, Exhibits Antitumor Effects in Preclinical Tumor ModelsKoji Ichikawa, Satoshi Ito, Emi Kato, et al.
Investigational New Drugs|January 7, 2021
TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathwaysAkihiro Miura, Hiroshi Sootome, Naoya Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2009
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitorsYoshiyuki Sato, Yu Onozaki, Tetsuya Sugimoto, et al.
Pageof 1